Genome-wide expression analysis of cells expressing gain of function mutant D374Y-PCSK9

Journal of Cellular Physiology

Volumn 217, Issue 2, 2008, Pages 459-467

  Ranheim, Trine ^a   Mattingsdal, Morten ^a   Lindvall, Jessica M ^b   Holla, Øystein L ^a   Berge, Knut Erik ^a   Kulseth, Mari Ann ^a   Leren, Trond P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

D374Y PROTEIN; PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9; SERINE PROTEINASE; UNCLASSIFIED DRUG; CCL5 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 8; MESSENGER RNA; PCSK9 PROTEIN, HUMAN; RANTES;

ARTICLE; CHOLESTEROL SYNTHESIS; D374Y GENE; DATA ANALYSIS; DNA MICROARRAY; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 GENE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STEROL METABOLISM; STRESS; CULTURE MEDIUM; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; LIPID METABOLISM; LIVER; METABOLISM; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CHEMOKINE CCL5; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INTERLEUKIN-8; LIPID METABOLISM; LIVER; MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE ENDOPEPTIDASES; STRESS; TRANSFECTION;

EID: 51449103813     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21519     Document Type: Article

References (47)

1. Alcivar A, Hu S, Tang J, Yang X. 2003. DEDD and DEDD2 associate with caspase-8/10 and signal cell death. Oncogene 22:291-297.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29.
3. Balasubramanian A, Ganju RK, Groopman JE. 2003. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem 278:35755-35766.
4. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. 2001. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279-284.
5. Benjannet S, Rhainds D, Essalmani R, Mayne J, Wickham L, Jin W, Asselin MC, Hamelin J, Varret M, Allard D, Trillard M, Abifadel M, Tebon A, Attie AD, Rader DJ, Boileau C, Brissette L, Chretien M, Prat A, Seidah NG. 2004. NARC-I/PCSK9 and its natural mutants: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem 279:48865-48875.
6. Benjannet S, Rhainds D, Hamelin J, Nassoury N, Seidah NG. 2006. The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: Functional consequences of natural mutations and post-translational modifications. J Biol Chem 281:30561-30572.
7. Bingham B, Shen R, Kotnis S, Lo CF, Ozenberger BA, Ghosh N, Kennedy JD, Jacobsen JS, Grenier JM, DiStefano PS, Chiang LW, Wood A. 2006. Proapoptotic effects of NARC 1 (= PCSK9), the gene encoding a novel serine proteinase. Cytometry A 69:1123-1131.
8. Brown DA, London E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221-17224.
9. Cameron J, Holla OL, Ranheim T, Kulseth MA, Berge KE, Leren TP. 2006. Effect of mutations in the PCSK9 gene on the cell surface LDL receptors. Hum Mol Genet 15:1551-1558.
10. Chang TY, Chang CC, Ohgami N, Yamauchi Y. 2006. Cholesterol sensing, trafficking, and esterification. Annu Rev Cell Dev Biol 22:129-157.
11. Costet P, Cariou B, Lambert G, Lalanne F, Lardeux B, Jarnoux AL, Grefhorst A, Staels B, Krempf M. 2006. Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c. J Biol Chem 281:6211-6218.
12. Davies JP, Ioannou YA. 2000. Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. J Biol Chem 275:24367-24374.
13. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4:3.
14. Falcon S, Gentleman R. 2007. Using GOstats to test gene lists for GO term association. Bioinformatics 23:257-258.
15. Fink M, Acimovic J, Rezen T, Tansek N, Rozman D. 200S. Cholesterogenic lanosterol 14alpha-demethylase (CYP51) is an immediate early response gene. Endocrinology 146:5321-S331.
16. Fisher TS, Lo SP, Pandit S, Mattu M, Santoro JC, Wisniewski D, Cummings RT, Calzetta A, Cubbon RM, Fischer PA, Tarachandani A, De FR, Wright SD, Sparrow CP, Carfi A, Sitlani A. 2007. Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation. J Biol Chem 282:20502-20512.
17. Gautier L, Cope L, Bolstad BM, Irizarry RA. 2004. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307-315.
18. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: Open software development for computational biology and bioinformatics, Genome Biol 5:R80.
19. Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343:425-430.
20. Holla OL, Cameron J, Berge KE, Ranheim T, Leren TP. 2007. Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly. BMC Cell Biol 8:9.
21. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 100:12027-12032.
22. Horton JD, Cohen JC, Hobbs HH. 2007. Molecular biology of PCSK9: Its role in LDL metabolism. Trends Biochem Sci 32:71-77.
23. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70.
24. Incardona JP, Eaton S. 2000. Cholesterol in signal transduction. Curr Opin Cell Biol 12:193-203.
25. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
26. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain CJ. 2007. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46:823-830.
27. Lagace TA, Curtis DE, Garuti R, McNutt MC, Park SW, Prather HB, Anderson NN, Ho YK, Hammer RE, Horton JD. 2006. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J Clin Invest 116:2995-3005.
28. Lambert G. 2007. Unravelling the functional significance of PCSK9. Curr Opin Lipidol 18:304-309.
29. Maxwell KN, Breslow JL. 2005. Proprotein convertase subtilisin kexin 9: The third locus implicated in autosomal dominant hypercholesterolemia. Curr Opin Lipidol 16:167-172.
30. Maxwell KN, Fisher EA, Breslow JL. 2005. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci USA 102:2069-2074.
31. McClintick JN, Edenberg HJ. 2006. Effects of filtering by Present call on analysis of microarray experiments. BMC Bioinform 7:49.
32. McNutt MC, Lagace TA, Horton JD. 2007. Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells. J Biol Chem 282:20799-20803.
33. Murooka TT, Wong MM, Rahbar R, Majchrzak-Kita B, Proudfoot AE, Fish EN. 2006. CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCLS aggregation. J Biol Chem 281:25184-25194.
34. Naureckiene S, Ma L, Sreekumar K, Purandare U, Lo CF, Huang Y, Chiang LW, Grenier JM, Ozenberger BA, Jacobsen JS, Kennedy JD, DiStefano PS, Wood A, Bingham B. 2003. Functional characterization of Narc 1, a novel proteinase related to proteinase K. Arch Biochem Biophys 420:55-67.
35. Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R. 1996. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev 10:2903-2911.
36. Pikuleva IA. 2006. Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 112:761-773.
37. Poirier S, Prat A, Marcinkiewicz E, Paquin J, Chitramuthu BP, Baranowski D, Cadieux B, Bennett HP, Seidah NG. 2006. Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system. J Neurochem 98:838-850.
38. Schroeder F, Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Huang H, Starodub O, Chao H, Yang H, Frolov A, Kier AB. 2001. Recent advances in membrane microdomains: Rafts, caveolae, and intracellular cholesterol trafficking. Exp Biol Med (Maywood) 226:873-890.
39. Schuchmann M, Galle PR. 2001. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 13:785-790.
40. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A, Chretien M. 2003. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation. Proc Natl Acad Sci USA 100:928-933.
41. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
42. Soutar AK, Naoumova RP. 2007. Mechanisms of disease: Genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4:214-225.
43. Van HD, Rodenburg KW, Van der Horst DJ. 2005. Intracellular fate of LDL receptor family members depends on the cooperation between their ligand-binding and EGF domains. J Cell Sci 118:1309-1320.
44. Wang MD, Franklin V, Sundaram M, Kiss RS, Ho K, Gallant M, Marcel YL. 2007. Differential regulation of ATP binding cassette protein A1 expression and ApoA-1 lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages. J Biol Chem 282:22525-22533.
45. Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119.
46. Zhang DW, Lagace TA, Garuti R, Zhao Z, McDonald M, Horton JD, Cohen JC, Hobbs HH. 2007. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J Biol Chem 282:18602-18612.
47. Zhao Z, Tuakli-Wosornu Y, Lagace TA, Kinch L, Grishin NV, Horton JD, Cohen JC, Hobbs HH. 2006. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am J Hum Genet 79:514-523.